Haviland Kate Insider Trades

Insider Trading History

Track insider trading activity for Haviland Kate. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Blueprint Medicines
Blueprint Medicines BPMC
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jul 17, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$9.16M 70,729 shares
$129.46
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Chief Executive Officer
Holding Value $38.2M 295,139 shares
Last Trade
Jul 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.7M 129,210 shares
$129.46
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Chief Executive Officer
Holding Value $9.16M 70,729 shares
Last Trade
Jul 17, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$85.6M 661,528 shares
$129.46
$129.46
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
Director
Holding Value $121k 36,000 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$266k 36,000 shares
$7.38
$3.37
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Director
Holding Value $485k 23,746 shares
Last Trade
Jun 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$273k 23,746 shares
$11.48
$20.41
Blueprint Medicines
Blueprint Medicines BPMC
CHIEF EXECUTIVE OFFICER
Holding Value $21.7M 167,827 shares
Last Trade
Apr 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$216k 2,498 shares
$86.65
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
CHIEF EXECUTIVE OFFICER
Holding Value $21.8M 168,427 shares
Last Trade
Mar 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.43M 16,151 shares
$88.80
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
CHIEF EXECUTIVE OFFICER
Holding Value $23.9M 184,578 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.8M 70,400 shares
$96.57
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
CHIEF EXECUTIVE OFFICER
Holding Value $19.3M 149,378 shares
Last Trade
Jan 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$159k 1,446 shares
$110.24
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
CHIEF EXECUTIVE OFFICER
Holding Value $19.8M 152,777 shares
Last Trade
Nov 29, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$227k 2,353 shares
$96.60
$129.46
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Director
Holding Value $485k 23,746 shares
Last Trade
Sep 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Director
Holding Value $152k 7,437 shares
Last Trade
Sep 12, 2024 Sale
No data
No data
$20.41
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
Director
Holding Value $101k 30,000 shares
Last Trade
Jun 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210k 30,000 shares
$7.00
$3.37
Blueprint Medicines
Blueprint Medicines BPMC
CHIEF EXECUTIVE OFFICER
Holding Value $19.8M 153,177 shares
Last Trade
Mar 07, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.13M 12,464 shares
$90.69
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
CHIEF EXECUTIVE OFFICER
Holding Value $21.4M 165,641 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.61M 80,000 shares
$95.12
$129.46
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
Director
Holding Value $101k 30,000 shares
Last Trade
Jun 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$94.8k 30,000 shares
$3.16
$3.37
Blueprint Medicines
Blueprint Medicines BPMC
Holding Value $16.3M 125,853 shares
Last Trade
Mar 06, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$303k 6,640 shares
$45.69
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Holding Value $17.1M 132,281 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.45M 80,000 shares
$43.15
$129.46
Blueprint Medicines
Blueprint Medicines BPMC
Director, CHIEF EXECUTIVE OFFICER
Holding Value $11.9M 92,281 shares
Last Trade
Nov 03, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$48.4k 1,100 shares
$43.98
$129.46
Fulcrum Therapeutics
Fulcrum Therapeutics FULC
Director
Holding Value $64k 19,000 shares
Last Trade
Jun 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.2k 19,000 shares
$5.22
$3.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up